Puhlmann Markus 4
4 · Perspective Therapeutics, Inc. · Filed Mar 4, 2026
Insider Transaction Report
Form 4
Puhlmann Markus
Chief Medical Officer
Transactions
- Award
Stock option (right to buy)
[F1][F2]2026-03-02+150,000→ 150,000 totalExercise: $5.35Exp: 2036-03-02→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]The option grant was approved by the Compensation Committee of the Issuer's Board of Directors on February 4, 2026, with a grant date of March 2, 2026 (the "Grant Date"), and represents the Reporting Person's annual equity award for 2026.
- [F2]Option vests and becomes exercisable over four years in 48 substantially equal monthly installments beginning on the date that is one month after the Grant Date, subject to the Reporting Person's continued service on each vesting date.
Signature
/s/ Markus Puhlmann by Chris Nenno, as Attorney-in-Fact|2026-03-04